NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Persistence Market Research (P) Ltd
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR - According to a report by Persistence Market Research (PMR), the Australia nitric acid market, which was valued at $725.3 million in 2016 is anticipated to grow 1.8X, reaching $1.3 billion by 2024-end
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR

 

NewswireToday - /newswire/ - New York, NY, United States, 2017/06/28 - According to a report by Persistence Market Research (PMR), the Australia nitric acid market, which was valued at $725.3 million in 2016 is anticipated to grow 1.8X, reaching $1.3 billion by 2024-end.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

In terms of volume share, market is expected to increase at 7.8% CAGR during 2016-2024. The report by PMR titled ‘Australia Nitric Acid Market: Industry Analysis and Forecast, 2016-2024’, provides an in-depth analysis on the performance of Australian nitric acid market, along with important trends and factors influencing the market.

Growing mining activities and expansion in capacity of facilities of ammonium nitrate are the factors expected to fuel the growth of nitric acid market in Australia during 2016-2024. An increase in demand for ammonium nitrate explosives has resulted in an increase in production of ammonium nitrate. This is expected to fuel demand for nitric acid during 2016-2024.

Due to the high dependency of ammonium nitrate explosives on mining exploration activities, the increase in mining exploration activities in Australia, especially in Queensland and Western Australia is set to witness growth in the production as well as consumption in the country. However, the rise in alternatives being developed for ammonium nitric-based explosives could hamper the growth of Australian nitric acid market.
In terms of application of nitric acid, the explosives accounted for volume share of 90% in 2015. However, registering 8.0% CAGR during the forecast period, explosives is expected to influence the Australian nitric acid market. Non-fuming product is expected to have largest share in nitric acid market in the country, registering 8.2% CAGR during 2016-2024. This will also create an opportunity of $580.4 million in the region.

The market value of non-fuming product is expected to rise to $1.24 billion by 2024-end from $609.7 million in 2015. Fuming nitric acid applied in litho printing and precious metal refining is anticipated to act as a driving force in growth of fuming segment, by application. In 2015, in terms of value, commercial grade accounted for 95.3% market share of nitric acid in Australia. Commercial grade is expected to expand at 7.9% CAGR between 2016 and 2024. In 2015, by application of nitric acid, explosives accounted for 95.4% Australia nitric acid market share on basis of value. The explosives market share in terms of value is expected to register 8.0% CAGR during 2016-2024.

Region-wise, the report has segmented Australia nitric acid market into Queensland, New South Wales, Western Australia, Victoria and rest of Australia. Among all these regions, Western Australia and Queensland are considered to be the largest market in Australia for nitric acid. In 2015, both the regions together accounted for 58.0% market share. According to the report, during 2016-2024, Queensland, Western Australia and New South Wales will be considered as the most attractive markets in Australia for nitric acid. Nitric acid consumption in all these three regions together was projected to reach 1,444.9 kilotons in 2016 end.

The report has also profiled some of the leading players in nitric acid market in Australia such as Energy & Fertilizers, Orica Limited, Incitec Pivot Limited and Wesfarmers Chemicals.

About Persistence Market Research (PMR)

Persistence Market Research (persistencemarketresearch.com) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Persistence Market Research (P) Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Rahul Singh - PersistenceMarketResearch.com 
646-568-7751 sales[.]persistencemarketresearch.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Persistence Market Research (P) Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Persistence Market Research (P) Ltd / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Celltrion Pharm Selects TrackWise QMS for Scalability and Data Integrity
Ipsen Adds Another Program into its Pre-clinical R&D Oncology Pipeline through An Exclusive Worldwide Collaboration with Accent Therapeutics
Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with its AI Immunology Platforms
Kyowa Hakko Acclaimed by Frost & Sullivan for its Non-GMO, Allergen-free, Immune Support Paraprobiotic Ingredient, IMMUSE™
DSM to Acquire First Choice Ingredients to Accelerate Growth in Food and Beverage
STEMCELL Technologies Launches Human Pluripotent Stem Cell Characterization and Banking Services in Partnership with WiCell
Biocon Selects TrackWise to Enable Enterprise Quality Management Across Global Biopharmaceutical Operations
STEMCELL Technologies and Hubrecht Organoid Technology to Partner on Non-Oncology Organoid Drug Screening Services
Ipsen and Exicure Enter into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders
Ipsen Strengthens its Pre-clinical Oncology Pipeline with An Exclusive Worldwide-collaboration with BAKX Therapeutics, Inc. for BKX-001
Pharma and Biotech to Highly Invest in RNA Therapeutics to Expedite Research & Development across the Globe Finds Frost & Sullivan
Parexel Commended by Frost & Sullivan for Developing a Flexible and Agile Delivery Model to Improve Clinical Trial Outcome
Ipsen and IRLAB Enter Exclusive Worldwide Licensing Agreement Aimed to Improve the Lives of People Living with Parkinson’s Disease
Exelixis and Ipsen Announce Cabozantinib in Combination with An Immune Checkpoint Inhibitor Significantly Improved Progression
Ipsen Opts-in to Join Exelixis with Ongoing Development of Cabometyx® for People Living with A Form of Thyroid Cancer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  MONOVERSE USA, Inc.





 
  ©2021 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)